Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1141.97
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 10 EP applications Lucy Whetton has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 17, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12713175

FERMENTATION PROCESS

IPC classification:
A61K 39/02, C07K 14/195, C07K 14/34, C12P 21/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14154664

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

IPC classification:
A61K 31/495, A61K 31/50, A61K 31/5025, A61K 31/5377, A61P 3/10, A61P 9/02, A61P 29/00, C07D 471/06, C07D 487/12, C07D 487/14
Agent:
Jones Day
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12707745

PROCESS FOR CONJUGATION OF BACTERIAL ANTIGEN TO A CARRIER PROTEIN

IPC classification:
A61K 39/02, A61K 47/48, A61P 31/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12808661

BIOMARKERS FOR KAWASAKI DISEASE

IPC classification:
C12Q 1/68, G01N 33/564
Applicant:
Baylor Research Institute
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12805890

METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES

IPC classification:
C07K 16/22
Applicant:
University of Michigan
Applicant:
Amgen Inc
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13755612

METHOD OF INTRODUCING NUCLEIC ACID INTO PLANT CELLS

IPC classification:
A01H 1/00, C07K 7/06, C07K 7/08, C07K 14/00, C12N 15/09
Applicant:
Kabushiki Kaisha Riken
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13761285

EARLY DETECTION OF TUBERCULOSIS TREATMENT RESPONSE

IPC classification:
C12Q 1/68, G01N 33/48, G01N 33/68
Applicant:
Baylor Research Institute
Applicant:
Medical Research Council
Applicant:
Imperial College Healthcare NHS Trust
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13827110

GLYCOFORM DETECTION METHOD AND GLYCOFORM DETECTION DEVICE

IPC classification:
G01N 33/53
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14842687

ANTHRACNOSE RESISTANCE-ASSOCIATED MARKER FOR PLANT OF GENUS FRAGARIA, AND USE THEREOF

IPC classification:
A01H 5/00, C12N 15/09, C12Q 1/68
Applicant:
Toyota Motor Corporation (Toyota Jidosha Kabushiki Kaisha)
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11777005

CRYSTALINE (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8,9-DIHYDRO-2H-PYRIDO[4,3,2-DE]PHTALAZIN-3(7H)-ONE TOSYLATE SALT

IPC classification:
A61K 31/5025, A61P 35/00, C07D 471/06
Agent:
Multiple attorneys, Jones Day
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature